In contrast to these findings, previous studies have provided compelling evidence that increased PKCα expression leads to a more aggressive phenotype20, 21 and is associated with resistance to cytostatic drugs in breast cancer cell lines22, 23. This evidence concerns the gene PRKCA and breast carcinoma.